The Platform for Research and Inspiration in Regulatory Science invited Dr. Lawrence Liberti, Director of the D.K. Kim International Center for Regulatory Science, University of Southern California (USC) on September 4, 2024, to give a lecture titled Academic Relationships that Support Pharmaceutical Excellence: The Role of Centers of Excellence. The lecture explored how academic institutions promote the development of pharmaceuticals and regulatory science through Centers of Excellence (CoEs). Using the USC as an example, the D.K. Kim International Center for Regulatory Science provides specialized training and practical research, dedicated to cultivating professionals capable of addressing global regulatory challenges. The presentation highlighted the core of regulatory science, emphasizing its crucial role in ensuring the safety and efficacy of pharmaceuticals and medical products. CoEs advance global regulatory alignment through collaboration between government, industry, and academia, driving innovation and high-impact research.
國際藥政法規科學研究平台於2024年9月4日,邀請南加州大學 (University of Southern California, USC) D.K. Kim International Center for Regulatory Science主任 Lawrence Liberti博士,以Academic Relationships that Support Pharmaceutical Excellence: The Role of Centers of Excellence為演講主題,探討學術機構如何透過卓越中心 (Centers of Excellence, CoEs) 促進製藥與法規科學的發展。以USC為例,該校的D.K. Kim國際法規科學中心提供專業訓練與實務研究,致力於培養能夠應對全球法規挑戰的專業人才。演講中介紹了法規科學的核心,強調其在確保藥品及醫療產品的安全性與有效性中的關鍵作用。卓越中心透過與政府、產業和學術界的合作,推動創新和高影響力的研究,促進全球法規一致性。